Navigation Links
Quincy Bioscience Receives Patent for Jellyfish Protein Aequorin
Date:7/7/2010

Quincy Bioscience, a research-based biotechnology company, announced the issuance of United States patent No.7,671,015. The patent covers the use of aequorin-containing compounds for the purpose of preventing and alleviating symptoms and disorders related to calcium imbalance which include Alzheimer's disease.

Madison, Wis (Vocus) July 7, 2010 -- Quincy Bioscience, a research-based biotechnology company, announced the issuance of United States patent No.7,671,015. The patent covers the use of aequorin-containing compounds for the purpose of preventing and alleviating symptoms and disorders related to calcium imbalance.

“Quincy Bioscience continues to strengthen its position in developing this novel calcium-binding protein as a platform technology,” said Mark Underwood, president of Quincy Bioscience. “The neuron’s ability to manage calcium and maintain homeostasis is fundamental to proper function. Research has proven the cell’s inability to regulate calcium is a key pathophysiological component in many different brain disorders, including Alzheimer’s disease. Based on our ongoing research of aequorin in various health conditions and what we know about the role of calcium in the body, we expect aequorin to be a vital protein in many aspects of healthy aging.”

Aequorin, which comes from a species of jellyfish called Aequorea victoria, is a calcium-binding protein. In humans calcium-binding proteins are utilized to maintain calcium balance which is critical to proper cell function. Aequorin has proven to be neuroprotective in pre-clinical studies performed at the University of Wisconsin-Milwaukee and has shown to be effective at improving aspects of cognition such as spatial working memory and executive function in human studies conducted by Quincy Bioscience.

About Quincy Bioscience
Quincy Bioscience is a biotechnology company based in Madison, Wisconsin. Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight the aging process. The company's products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms.

###

Read the full story at http://www.prweb.com/releases/2010/07/prweb4235874.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Quincy Bioscience Announces Encouraging Preliminary Results of Randomized, Double-Blind, Placebo-Controlled Memory Study
2. Quincy Bioscience Sponsors Multiple Sclerosis (MS) Scholarship Program
3. Quincy Bioscience Launches HOPETrials.com; Research Studies More Accessible For Participants
4. Flagship Biosciences Partners with a Leading IHC CLIA Laboratory for Companion Diagnostics Service
5. Martek Biosciences Chief Scientific Officer, Dr. Norman Salem, 2010 Recipient of Alex Leaf Distinguished Scientist Award
6. Martek Biosciences and the National Center for Creative Aging Introduce New Brain Health Awareness Campaign, "Beautiful Minds: Finding Your Lifelong Potential"
7. Exalenz Bioscience Expands Market Coverage for the BreathID Breath Test System
8. Digital Pathology Services Firm Flagship Biosciences Appoints New CEO
9. Southridge LLC Provides Equity Capital Through Private Agreement with PuraMed Bioscience
10. Childrens Hospital Los Angeles oncologist receives $50,000 Hyundai Scholar Award
11. Stamen Medical Systems Receives Medicare Re-Accreditation and The Exemplary Provider Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Quincy Bioscience Receives Patent for Jellyfish Protein Aequorin
(Date:4/28/2016)... ... 2016 , ... For the 10,000 Americans who turn 65 on any given ... overall well-being: mental health. Now, a new book—Staying Sharp For Dummies (Paper; ISBN: 978-1-119-18779-0; ... which can include everything from honing your memory and managing stress to eating healthy ...
(Date:4/28/2016)... ... 2016 , ... Boston Laser is now offering a novel treatment for Keratoconus ... of the application of Riboflavin, a vitamin, to the cornea. This, combined with UV ... cornea to slow the progression of keratoconus. , Keratoconus is the continuous thinning and ...
(Date:4/28/2016)... ... April 28, 2016 , ... The USDA recently released its updated ... latest nutritional science. While there is a lot of information available in the report, ... the April 2016 issue of Harvard Men's Health Watch . , These ...
(Date:4/28/2016)... ... April 28, 2016 , ... Zerorez Franchising Systems, ... March 2-4. The conference featured several collaborative breakout sessions, presentations, an award banquet, ... franchisees felt they were given tools and resources to assist with operational growth ...
(Date:4/28/2016)... ... 2016 , ... It was the five star ratings and excellent reviews by ... Top Rated Atlanta Plastic Surgeon by Find Local Doctors. Dr. ... Specialists, P.C. This recognition is one of many achievements and awards that Dr. Jones ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... YORK , April 28, 2016  The blood ... 275 million dollars, according to Kalorama Information and The ... typing, immunoassays and nucleic acid testing.  The healthcare research ... made progress in developing blood collection stations and in ... made in Kalorama Information,s report, Blood Testing ...
(Date:4/28/2016)... Dr. Vivek Ahuja , ... phen Schmidt Join the Growing ... solutions for life sciences, today announced key new leaders have joined ... to a growing business.  This will bolster the company,s safety business ... joined ArisGlobal in the position of Vice President - Safety. George ...
(Date:4/28/2016)... FREMONT, Calif. , April 28, 2016 ... Enterprise Validation Lifecycle Management Solutions (VLMS) today ... products and services for sufferers of chronic ... management System to manage their corporate validation ... been seeking a software solution to manage ...
Breaking Medicine Technology: